Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-742457 versus donepezil in Alzheimer's disease (AZ3110865)
2008-000826-37Phase 2Completed
- Sponsor
- GSK
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of intepirdine in Alzheimer's disease (AD) (2 arms), sponsored by GSK. Primary endpoint: Change from baseline in ADAS-Cog total score at Week 24. Started May 2008; status: completed.
02
Drugs
intepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2008-000826-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000826-37.